February 2020 | Crumdale Partners

Employers Begin Taking Steps to Combat the Coronavirus

It is estimated over 75,000 people worldwide have been infected with the coronavirus, with death figures approaching 2800 people. The fear of this potentially deadly virus has employers beginning to take steps to protect their employees. Coronavirus (2019-nCoV) was first identified in Wuhan, Hubei Province, China. Coronaviruses are a large family of viruses that are common [...]

Employers Begin Taking Steps to Combat the CoronavirusJessica Willingham2023-05-03T15:58:12+00:00

FDA Approves First Medication for Treatment of Peanut Allergy
Gallery
FDA Approves First Medication for Treatment of Peanut Allergy

Uncategorized

FDA Approves First Medication for Treatment of Peanut Allergy

On January 31st, 2020, the U.S. Food and Drug Administration (FDA) approved Palforzia to reduce the risk of allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts. Peanut allergy is a condition in which the body’s immune system mistakenly identifies small amounts of peanut as harmful. When this occurs individuals may experience [...]

FDA Approves First Medication for Treatment of Peanut AllergyJessica Willingham2023-01-25T01:07:31+00:00